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Abstract
Background: Endothelial progenitor cells (EPCs) were shown to have angiogenic potential contributing to neovascular-
ization. However, a clear definition of mouse EPCs by cell surface markers still remains elusive. We hypothesized that CD34
could be used for identification and isolation of functional EPCs from mouse bone marrow.
Methodology/Principal Findings: CD34
+ cells, c-Kit
+/Sca-1
+/Lin
2 (KSL) cells, c-Kit
+/Lin
2 (KL) cells and Sca-1
+/Lin
2 (SL) cells
were isolated from mouse bone marrow mononuclear cells (BMMNCs) using fluorescent activated cell sorting. EPC colony
forming capacity and differentiation capacity into endothelial lineage were examined in the cells. Although CD34
+ cells
showed the lowest EPC colony forming activity, CD34
+ cells exhibited under endothelial culture conditions a more adherent
phenotype compared with the others, demonstrating the highest mRNA expression levels of endothelial markers vWF, VE-
cadherin, and Flk-1. Furthermore, a dramatic increase in immediate recruitment of cells to the myocardium following
myocardial infarction and systemic cell injection was observed for CD34
+ cells comparing with others, which could be
explained by the highest mRNA expression levels of key homing-related molecules Integrin b2 and CXCR4 in CD34
+ cells.
Cell retention and incorporation into the vasculature of the ischemic myocardium was also markedly increased in the CD34
+
cell-injected group, giving a possible explanation for significant reduction in fibrosis area, significant increase in
neovascularization and the best cardiac functional recovery in this group in comparison with the others.
Conclusion: These findings suggest that mouse CD34
+ cells may represent a functional EPC population in bone marrow,
which could benefit the investigation of therapeutic EPC biology.
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Introduction
Since endothelial progenitor cells were shown to contribute to
tissue vascularization after ischemic events in limbs, retina and
myocardium [1,2], EPC therapy has been studied as a new
strategy in regenerative medicine. Rapid revascularization of
injured and ischemic organs is essential to restore organ function.
Thus EPC therapy depends largely on the functional activity of
EPCs. The usage of EPC populations having different properties
resulted in the existing controversial findings of EPC therapy [3,4].
CD34 is a 105- to 120-kD transmembrane cell surface
glycoprotein, which is selectively expressed within the human
and murine hematopoietic systems on stem and progenitor cells
[5,6,7]. It is also expressed in vascular endothelial cells. Human
CD34
+ endothelial progenitor cells have been widely used for
animal experiments and clinical use [8,9,10,11,12]. However, little
research has been conducted to identify mouse bone marrow-
derived CD34
+ cells regarding their angiogenic properties.
Whereas c-Kit
+/Sca-1
+/Lin
2 cells have been widely used as
mouse endothelial progenitor cells [13,14,15,16]. In our prelim-
inary studies, we found that key homing-related molecules,
Integrin b2 and CXCR4, were higher expressed in bone marrow
CD34
+ cells rather than in other commonly used c-Kit
+/Sca-1
+/
Lin
2 cells (KSL), c-kit
+/Lin
2 cells (KL) [17], Sca-1
+/Lin
2 cells
(SL) [2].
Integrins are crucial transmembrane molecules that mediate cell
adhesion, migration, and the homing of progenitor cells such as
EPCs to ischemic tissue, possibly through the enhanced angio-
genesis by homing stem cells [18]. The b2-integrins are involved in
the homing of EPCs to the site of ischemia and are essential for
their neovascularization capacity in vivo [19]. The activation of
b2-integrin on EPCs has been shown to significantly improve the
neovascularization capacity in vivo in a model of hindlimb
ischemia [20]. CXCR4 is also crucial for homing of transplanted
EPC into ischemic tissues. CXCR4 blockade is associated with an
impaired incorporation of EPC into sites of ischemia-induced
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 neovascularization and disturbed restoration of blood flow to
ischemic limbs, suggesting that CXCR4 is important for
therapeutic integration of EPC into the vascular bed [21].
Based on the above concerns and the mechanistic findings, we
sought to identify a functional mouse EPC population via
enhanced homing mechanism. In pursuit of this goal, we analyzed
the EPC properties of mouse bone marrow derived c-Kit
+/Sca-
1
+/Lin
2 cells (KSL), c-kit
+/Lin
2 cells (KL), Sca-1
+/Lin
2 cells (SL)
and together with CD34
+ cells. Our results suggest that mouse
CD34
+ cells may represent a functional EPC population in mouse
bone marrow.
Results
Population of KSL, KL, SL and CD34
+ cells
Initially we determined the populations to investigate. For KL,
SL and KSL cell isolation, lineage positive cells, counting about
90%, were depleted from total BMMNCs. KL cells and SL cells
counted 37.3760.04% and 13.2760.01% respectively in lineage
negative BMMNCs. KSL cells were included in KL or SL cells,
and counted 5.9760.01% in lineage negative BMMNCs. For
CD34
+ cell isolation, CD34
+ cells were 12.2360.02% in total
BMMNCs (Figure 1a). The levels of expression of CD34 by KSL,
KL and SL cells are 89.8%, 72% and 55.9%, respectively
(Figure S1).
In summary, c-Kit
+/Lin
2 (KL, 3.73760.004%) cells, Sca-1
+/
Lin
2 (SL, 1.32760.001%) cells, Sca-1
+/c-Kit
+/Lin
2 (KSL,
0.59760.001%) cells and CD34
+ cells (12.2360.02%) were
isolated from mouse total BMMNCs by FACS.
Low colony forming activity in CD34
+ cells
First, we evaluated the EPC colony forming capacities of KSL,
KL, SL and CD34
+ cells as described before [16,22]. An EPC-
colony forming assay (CFA) was recently established in our
laboratory. EPCs can form two types of EPC colony clusters, small
(primitive) and large (definitive) EPC colonies. Small EPC colonies
contain mainly small and round cells, whereas large EPC colonies
are composed of large and spindle-shaped cells (Figure 1c). Both
colony types are positive for the uptake of Ac-LDL and for labeling
with an EC-specific marker, isolectin B4 (Figure 1d). In the current
study, KSL cells had the highest capacity to form both large and
small colonies (small colonies: 3467/500 cells, large colonies:
1663/500 cells) (Figure 1b). KL (small colonies: 862/500 cells,
large colonies: 662/500 cells) and SL cells (small colonies: 1364/
500 cells, large colonies: 663/500 cells) formed fewer colonies
than KSL cells but still overall more colonies than CD34
+ cells.
Figure 1. Isolation of KSL, KL, SL, and CD34
+ cells by FACS and EPC-CFA. a, Lineage depleted BMMNCs were stained with APC anti-c-kit and
PE anti-Sca-1 antibodies followed by FACS sorting. The cell fractions gated with black, red, and blue frames were defined as KSL, KL, and SL cells,
respectively. Also BMMNCs were stained with a FITC anti-CD34 antibody followed by FACS sorting for CD34 positive cells. b, The number of colonies
was counted in each group. Small EPC colony count in each group and large EPC colony count in each group. c, EPC-CFA was performed with KSL, KL,
SL, and CD34
+ cells, and the morphologies of small EPC colony and large EPC colony were dispalyed. The framed areas were magnified in lower
panels. d, Representative double staining for Fluorescein isolectin B4 (ILB4) and DiI-acLDL in KSL cell-formed colonies. All assays were triplicated and
demonstrated similar results.
doi:10.1371/journal.pone.0020219.g001
Mouse CD34
+ Cells Exhibit EPC Phenotype
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+ cells showed the lowest colony forming capacity (small
colonies: 261/500 cells, large colonies: 161/500 cells) (Figure 1b).
Phenotypes of large and small EPC colonies
Small and large EPC colonies were collected separately after 7
days culture in methylcellulose medium. The phenotypes were
analyzed by flow cytometry. The positive percentages of VE-
cadherin, Flk-1 and Tie-2 were 5.3%, 3.7%, 2.9% in large
colonies, respectively, 5.1%, 0.5%, 0.3% in small colonies,
respectively (Figure S2a and S2b); while the positive percentages
of c-Kit and Sca-1 were 4.8%, 4.4% in large colonies, respectively,
9.2%, 13.1% in small colonies, respectively (Figure S2a and S2b),
which indicates that large colonies are more differentiated than
small colonies. The positive percentages of CD19, CD3, CD14,
CD41 and CD45 were 2.5%, 3.2%, 1.4%, 7.5%, 99.9% in large
colonies, respectively, 0.1%, 0.2%, 0.3%, 9.1%, 100% in small
colonies, respectively (Figure S2a and S2b).
Enhanced endothelial phenotype of CD34
+ cells
following an adhesive culture assay
The cell culture assay was performed to further characterize all
cell populations. Cells were cultured in differentiation medium for
7 days. CD34
+ (172619 cells/mm
2) and KL cells (179628 cells/
mm
2) showed more numbers of adherent cells than KSL (133638
cells/mm
2) and SL cells (128619 cells/mm
2)( P,0.05, CD34 vs
SL; P,0.05, KL vs KSL and SL) (Figure 2a and 2b).
The expression of endothelial markers in cultured KSL, KL,
SL, and CD34
+ cells was assessed by fluorescent immunocyto-
chemical staining and real-time RT-PCR. Consistent with the
previous report that cultured EPCs express endothelial markers
such as VE-cadherin, vWF and Flk-1 [23], a significant number of
cells expressed VE-cadherin, vWF and Flk-1 protein in each group
(Figure 3a). RT-PCR revealed that at day three CD34
+ cells had
the highest mRNA expression levels of VE-cadherin, Flk-1 and
vWF (Figure 3b). While all the cells before culture expressed low
and similar levels of these markers (data not shown).
Higher angiogenic capacity in CD34
+ cells in vitro
The in vitro incorporation capacity of the cells was assayed via a
previously described tube formation assay system [24]. HUVECs
were employed to form tube-like structures. KSL, KL, SL and
CD34
+ cells were seeded together with HUVECs, incorporating
into tube-like structures and supporting their growth. One
thousand (1,000) DiI-labeled cells and 12,500 HUVECs were
seeded onto Matrigel-coated 96 well plates. After 24 hours in
culture, incorporation of each cell population into tube-like
structures formed by HUVECs was evaluated under fluorescence
microscopy. Augmented cell incorporation was found for the
CD34
+, KSL and KL groups compared to the SL group (CD34:
1663, KSL: 1362, KL: 1562, SL: 862; P,0.05, SL vs CD34,
KL and KSL) (Figure 4a and 4b).
Higher recruitment capacity of CD34
+ cells in vitro and in
vivo
Next, we examined the homing capacity of these cells in
mouse MI models. For tracking the fate of grafted EPCs in
mouse myocardium, transplanted cells were labeled with CM-
DiI after isolation by FACS and then delivered systemically three
days after MI induction. Heart samples harvested one day after
cell injection and examined for the presence of fluorescent-
labeled cells. DiI-positive cells were observed in the infarcted
myocardium of all examined groups (Figure 5a). However, the
most dramatic immediate cell recruitment to ischemic myocar-
dium was detected in the CD34
+ cell-injected group (CD34:
112641/mm
2,K S L :7 4 634/mm
2,K L :4 7 621/mm
2 and SL:
57624/mm
2; P,0.05, CD34 vs KSL, KL and SL) (Figure 5b).
No significant differences among the numbers of recruited cells
in the KSL, KL and SL groups could be observed. Integrin b2
has been reported previously to be critical adhesion molecules
for the homing of EPCs to ischemic tissue [18,19,20,25]. SDF1/
CXCR4 axis has also been shown to be one of the major
chemokine/receptor signalings for EPC recruitment [26,27,28].
CXCR4 is also crucial for homing of transplanted EPC into
ischemic tissues [21]. We thus assessed the mRNA expression
levels of these homing-related molecules in the cells that were
used for transplantation. We observed a marked up-regulation of
integrin b2 and CXCR4 in CD34
+ cells (Figure 5c and 5d). KL
cells also exhibited higher expression levels of CXCR4
(Figure 5d).
Figure 2. Culture assay with KSL, KL, SL, and CD34
+ cells. Freshly isolated KSL, KL, SL, and CD34
+ cells were cultured in 20%FBS/EGM-2MV
medium on vitronectin-coated 4 well-chamber slides for 7 days. a, The cells were washed by PBS for three times and stained with DAPI. b, The
numbers of adherent cells were counted and analyzed (n=3). The assay was triplicated and demonstrated similar results.
doi:10.1371/journal.pone.0020219.g002
Mouse CD34
+ Cells Exhibit EPC Phenotype
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reduced fibrosis in ischemic hearts by CD34
+
transplantation
To track the injected cells in vivo for 28 days, we employed cells,
isolated from ROSA mice, that constitutively express b-gal under
the regulation of LacZ gene. Thus, cell differentiation and
incorporation into the neovasculature of ischemic myocardium
four weeks after surgery can be detected as b–gal
+ cells by
immunohistochemistry. Double fluorescent immunostaining of
ischemic myocardium 28 days after surgery revealed that b-gal-
expressing EPCs (green) were frequently observed in ischemic
border zone and co-localized with vessels perfused with BS-1 lectin
(red) in the CD34
+ cell-injected group (Figure 6a). In contrast, a
few KSL, KL and SL cells were observed in the ischemic border
zone and incorporated into vessels (Figure 6a). Quantitative
analysis for cell retention demonstrated that the number of
Figure 3. Assessment of endothelial markers in cultured KSL, KL, SL, and CD34
+ cells by immunocytostaining and real-time RT-PCR.
Freshly isolated cells were cultured in 20%FBS/EGM-2MV medium on vitronectin-coated 4 well-chamber slides for 7 days. a, Adherent cells were
stained with endothelial markers, VE-cadherin, vWF, and Flk-1. b, mRNA expression levels of the markers in 3-days cultured cells were assessed by
quantitative real-time RT-PCR. The mRNA expressions were normalized to GAPDH (n=3). All assays were triplicated and demonstrated similar results.
doi:10.1371/journal.pone.0020219.g003
Mouse CD34
+ Cells Exhibit EPC Phenotype
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the CD34
+ cell-injected group than those in the other groups
(Figure 6c).
In order to evaluate the size of MI, Masson’s trichrome staining
was performed with heart sections at day 28. Representative
images indicated that fibrosis area was stained in blue and intact
Figure 4. Tube formation assay by HUVECs incorporated with KSL, KL, SL, and CD34
+ cells. KSL, KL, SL, and CD34
+ cells were isolated via
FACS and stained with DiI. DiI-labeled cells and HUVECs were seeded onto Matrigel-coated 96 well plates in 1% FBS/EBM2-MV without growth
factors. After 24 hours in culture, incorporation of each cell population into tube-like structures formed with HUVECs was evaluated under
fluorescence microscopy. a, Incorporated DiI positive cells were indicated by arrows. b, Number of incorporated DiI positive cells into tube-like
structures was counted and averaged. All assays were triplicated and demonstrated similar results.
doi:10.1371/journal.pone.0020219.g004
Figure 5. Assessment of cell recruitment and detection of homing molecules in KSL, KL, SL, and CD34
+ cells. KSL, KL, SL, and CD34
+
cells were freshly isolated by FACS and stained with DiI. DiI-labeled cells were systemically injected into mice three days after MI induction, and heart
samples were examined histologically one day after cell injection. a, DiI positive cells (red) detected in ischemic myocardium under a fluorescence
microscope. b, Number of DiI positive cells was counted in the ischemic border zone (bilateral sides of peri-infarct area) and averaged (n=3). c and d,
KSL, KL, SL, and CD34
+ cells were freshly isolated by FACS, and Integrin b2 and CXCR4 gene expression levels of these cells were examined by
quantitative real-time RT-PCR. All assays were triplicated and demonstrated similar results.
doi:10.1371/journal.pone.0020219.g005
Mouse CD34
+ Cells Exhibit EPC Phenotype
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revealed that both the percent of fibrosis area in entire LV cross-
sectional area and the percent of scar length in entire internal LV
circumference were significantly reduced in the CD34
+ cell-
injected group compared with the KSL cell-injected group, the SL
cell-injected group and PBS group (Figure 7b and 7c). The
staining of in vivo-perfused BS1 lectin and a-smooth muscle actin
reflects angiogenesis in functional vessels in the peri-infarct
myocardium four weeks after MI in all groups (Figure 8a and
9a). The averaged capillary density in the bilateral ischemic border
zones of LV, an index of neovascularization, was significantly
greater in the CD34
+ cell-injected group compared to the KSL
cell-inject group and PBS group (CD34: 165640/mm
2, KL:
150625/mm
2, SL: 103635/mm
2, KSL: 80621/mm
2, PBS:
70613/mm
2; P,0.05, PBS vs CD34 and KL, KSL vs CD34
and KL) (Figure 8b). Although the averaged number of arterioles
was higher in the CD34
+ cell-injected group, no significant
difference could be found between any two groups (Figure 9b).
The KL cell-injected group also showed an increase in capillary
density (P,0.05, KL vs KSL and PBS), reduced fibrosis area
(P,0.05, KL vs KSL and PBS) and reduced fibrosis length
(P,0.05, KL vs KSL, SL and PBS).
Transplanted CD34
+ cells effectively preserve LV function
after MI
There were no significant differences in preoperative echocar-
diographic parameters, LVEDD (left ventricular end-diastolic
dimension), LVESD (left ventricular end-systolic dimension), EF
(ejection fraction) and FS (fractional shortening) among any
groups. Echocardiography performed 7 days and 28 days after cell
transplantation demonstrated that DLVEDD (day 28-day 7) was
significantly smaller in the CD34
+ cell-treated group than in the
PBS-, the KSL- and the SL-treated groups (P,0.05 vs PBS, KSL
and SL) (Figure 10a). The DLVEDD was also significantly smaller
in the KL-treated group than in the PBS- and the KSL-treated
groups (P,0.05) (Figure 10a). However, DLVEDD was similar in
the PBS-, the KSL- and the SL-treated groups (Figure 10a). The
DLVESD (day 28-day 7) was significantly smaller in the CD34
+
cell-treated group than in the PBS-, the KSL- and the SL-treated
groups (P,0.05 vs PBS, KSL and SL) (Figure 10b). The DEF (day
28-day 7) was significantly greater in the CD34
+ cell-treated group
than in the PBS-, the KSL- and the SL-treated groups (P,0.05 vs
PBS, KSL and SL) (Figure 10c). The DEF was also significantly
smaller in the PBS-treated group than in the KSL-, the KL- and
the SL-treated groups (P,0.05) (Figure 10c). The DFS (day 28-day
7) was significantly greater in the CD34
+ cell-treated group than in
the PBS-, the KSL-, the KL- and the SL-treated groups (P,0.05
vs PBS, KSL, KL and SL) (Figure 10d). The DFS was also
significantly smaller in the PBS-treated group than in the KSL-,
the KL- and the SL-treated groups (P,0.05) (Figure 10d). Overall,
transplantation of CD34
+ cells exhibited significant LV functional
recovery among all cell-transplanted groups following MI, which is
consistent with the results of histological analysis.
Discussion
The present study was designed to determine a functional
population for murine EPC transplantation by systemic injection.
The results indicated the CD34 could be a better marker for
isolating functional EPC populations in mouse bone marrow
compared with c-Kit, Sca-1 and their combination. We have
demonstrated that mouse bone marrow-derived CD34
+ cells
exhibit characteristics of endothelial progenitors both in vitro and
in vivo as follows: 1) CD34
+ cells possess highly adhesive feature
Figure 6. Assessment of cell incorporation into the neovasculature of the ischemic myocardium. KSL, KL, SL, and CD34
+ cells were
isolated by FACS from GtRosa26 transgenic mice expressing LacZ gene universally, and were systemically injected three days after MI induction. Heart
samples were harvested following BS1 lectin systemic perfusion 28 days after cell injection. a, Recruited cells visualized by immunofluorescent
staining for b-gal (green) and BS1 lectin perfused capillaries (red) were shown in all groups. Recruited cells co-localizing with capillaries were marked
by arrowheads and shown in yellow. b, A representative confocal image from the CD34
+ cell-injected group. c, The numbers of recruited cells that co-
localized with capillaries were counted under a fluorescence microscope separately and averaged.
doi:10.1371/journal.pone.0020219.g006
Mouse CD34
+ Cells Exhibit EPC Phenotype
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an adhesive cell phenotype despite of their less colony forming
capacity, 2) CD34
+ cells have a better homing capacity to ischemic
tissue through adhesion molecule and chemokine/receptor-
dependent mechanism, and 3) Recruited CD34
+ cells are
frequently incorporated into functional vessels contributing to
the reduction of MI size, the enhanced angiogenesis and the
significant LV functional recovery following MI.
Since phenotypic HSCs (c-Kit
+/Sca-1
+/Lin
2 cells) [29] have
been described to have the ability to give rise to endothelial
progeny [30,31,32], KSL cells have been widely used as mouse
EPCs [13,14,15,16], displaying colony forming capacity, endo-
thelial differentiation capacity and vasculogenic activity. In
addition, Takahashi et al [2] used Sca-1
+ cells from peripheral
blood as an EPC-enriched population and demonstrated their
differentiation into endothelial cells in mice with hindlimb
ischemia. Cheng et al [17] purified CD31
+/c-Kit
+/Lin
2 cells
from bone marrow and confirmed their contribution to neovas-
cularization following bone marrow transplantation. Very recent-
ly, Kim et al [33] has demonstrated high vasculogenic property of
CD31 positive cells in BMMNCs. On the other hand, Balsam et al
[34] and Murry et al [35] reported that mouse bone marrow
HSCs isolated as c-Kit
+/Lin
2 cells or c-Kit
+/Sca-1
+/Thy1.1
lo/
Lin
2 cells adopt mature haematopoietic fates in the infarcted
myocardium. Given the controversy and also considering that
CD34 expression patterns during early mouse development are
related to modes of blood vessel formation [7], we analyzed the
EPC properties of mouse bone marrow derived c-Kit
+/Sca-1
+/
Lin
2 cells (KSL), c-kit
+/Lin
2 cells (KL), Sca-1
+/Lin
2 cells (SL)
and together with CD34
+ cells. As for the adherent EPC
formation, CD34
+ cells and KL cells changed their phenotypes
more frequently into adherent cells than the others. We also
examined mRNA and protein expressions in CD34
+, KSL, KL
and SL cells cultured under an endothelial culture condition.
Although immunocytochemistry revealed that VE-cadherin, vWF
and Flk-1 were similarly positive in all types of cells, mRNA
expression of these markers was greatest in CD34
+ cells, suggesting
that endothelial differentiation may occur more robustly in CD34
+
cells than in the others. We also examined the expressions of
CD45 and another EC marker CD146. CD45 and CD146 were
expressed partially in the cells in each group (Figure S3),
suggesting that the cells were partially differentiated exhibiting
both hematopoietic and endothelial phenotypes. A few cells also
expressed CD34 during the culture (Figure S3).
The cell homing capacity to ischemic tissue is also one of the
unique characteristics in EPCs. The major distinct assortment of
EPCs is proposed to lay in their in vivo phenotype, distinguishing
‘‘circulating EPCs’’ from ‘‘tissue EPCs’’. Circulating EPCs can be
isolated from PB and BM and represent a population of suspended
non-adhesive cell phenotype. These cells migrate from their initial
protective niches in the BM into the blood stream, and home via
the circulatory system to sites undergoing vascular regeneration
and repair, transforming into local adhesive tissue EPCs.
Therefore, we further examined EPC groups regarding the
biological properties for homing in vitro and the pathophysiological
recruitment from circulation in vivo using a mouse MI model. The
most dramatic cell recruitment to ischemic myocardium immedi-
ately after MI was observed in the CD34
+ cell-injected group.
Figure 7. Histological analysis for MI size in ischemic myocardium. KSL, KL, SL, CD34
+ cells and PBS control were systemically injected 3 days
after MI induction. Heart samples were harvested following BS1 lectin systemic perfusion 28 days after cell injection. a, Heart sections were stainedb y
Masson’s Trichrome staining. Red indicates intact myocardium and blue indicates scared fibrosis area. b, The percent of fibrosis area in entire LV cross
sectional area was calculated and averaged (n=3). c, The percent of scar length in internal LV circumference was calculated and averaged (n=3).
doi:10.1371/journal.pone.0020219.g007
Mouse CD34
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critical for the homing and neovascularization capacity of EPCs.
They were significantly up-regulated in CD34
+ cells compared to
the others by RT-PCR analysis, providing a very possible
explanation for the most striking cell recruitment of CD34
+ cells
to ischemic myocardium. In fact, we also assessed many
angiogenic factors including VEGFs, Ang-1, IGF, PLGF and
SCF in all types of cells, but the expression levels of all these genes
were similar among them (data not shown). Therefore, the homing
activity is one of the crucial mechanisms in regard to revascular-
ization. With the most homing and recruited cells, the CD34
+ cell-
injected group performs the best. It is noteworthy that CD34
+ cells
and KL cells showed a similar adhesive capacity in vitro, while in
vivo they didn’t. We speculate that it is caused by the up-regulated
expressions of integrinb2 and CXCR4 in CD34
+ cells. Further-
more, the highest number of cells was incorporated into vascular
structure in the CD34
+ cell-injected group in the 28 days follow up
study, resulting in the reduced fibrosis, the increased vascularity
and the significantly enhanced LV functional recovery in the
ischemic myocardium. Another finding is that KL cell-injected
group also showed greater capillary density and smaller fibrosis
area/length than SL and KSL groups, possibly due to more
abundant incorporation into neovasculature. Since myocardial
regeneration requires vascular regeneration and cardiomyocyte
regeneration as well, the recruited cells might differentiate into
cardiomyocytes in addition to endothelial cells, as we observed for
human CD34
+ cells [36].
To make sure that vasculogenesis and the observed recruitment
capacities of mouse bone marrow CD34
+ cells indeed reflect the
characteristics of EPCs rather than mature endothelial cells (ECs),
we analyzed the presence and expression of several other cell
surface markers such as CD31, VE-cadherin, Flk-1 and Tie-2 in
the CD34
+ cell population by FACS analysis (Figure S4). Positive
percentages of CD31, VE-cadherin, Flk-1 and Tie-2 were 83%,
0.5%, 1.1% and 4%, respectively, indicating that no substantial
EC contamination of CD34
+ cells is present.
In the conventional EPC culture, two major cell types have been
shown to emerge out of MNC cultures: EC-like cells (i.e., early
EPC, cultured EPC) and endothelial outgrowth cells (i.e., EOCs)
[37]. While EOCs are proved to derive from endothelial colony
forming cells (ECFCs), EC-like cells have not been identified to
develop from any colony forming unit, although CFU-EC was
initially presumed as an origin of EC-like cells, but was later
defined as an aggregate of hematopoietic cells and EPCs. Lately, a
new EPC colony forming assay (EPC-CFA) has been developed,
challenging some of the classical views predominant in the field
and opening the possibility to illustrate the developmental
hierarchy of EPCs [15,16,22,38]. The methodological concept of
EPC-CFA was recently introduced and further developed for the
use of human EPCs (Masuda et al., revising in Circulation
Research). In this research, small-EPCs are characterized as
‘‘primitive EPCs’’, which are possibly derived from further
immature and proliferative EPCs, and large-EPCs as ‘‘definitive
EPCs’’ which are more prone to differentiation and promoting
EPC-mediated cell functions required for vasculogenesis. The
definitive EPCs are capable of differentiating into a non-colonizing
large EPC phenotype, similar to ‘‘EC-like cells (i.e., early EPC,
cultured EPC)’’ detected by conventional EPC culture [39,40,41].
Therefore, ‘‘EC-like cells’’ are speculated to represent further
differentiating EPCs, departed from the niche of colony forming
Figure 8. Histological analysis for capillary density in ischemic myocardium. KSL, KL, SL, CD34
+ cells and PBS control were systemically
injected 3 days after MI induction. Heart samples were harvested following BS1 lectin systemic perfusion 28 days after cell injection. a, Capillaries
were visualized as tubular structure perfused by BS1 lectin. b, The numbers of capillaries were counted in bilateral sides of the peri-infarct zone on LV
cross sections and averaged in each group (n=3), respectively.
doi:10.1371/journal.pone.0020219.g008
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demonstrate very similar expressional profiles and biological
functions to differentiated ECs such as human umbilical vein
ECs and human microvascular ECs, and are considered to be
generated from different stem cell fraction compared to EC-like
cells as previously reported [42,43,44]. Later studies by Case et al
or Timmermans et al demonstrated that CD34
+CD133
+VEGFR-
2
+ or CD133
+ cells are hematopoietic progenitor cells that do not
yield EOCs [44,45]. These findings support the idea that EOCs
are not likely to derive from hematopoietic stem cells (HSCs) or
hematopoietic progenitor cells (HPCs) originating from the BM,
while EC-like cells and two types of colonies in EPC-CFA are
relating to HSCs or HPCs. Therefore, the primary and original
phenotype of EPC-CFA and EC-like cells seems different from
EOCs (ECFCs), though it is not conclusive due to the immaturity
in respective EPC biology.
In terms of EPC colony forming activity, KSL cells formed a
substantially greater number of small (primitive) EPC colonies and
large (definitive) EPC colonies, especially small EPC colony
forming activity of KSL cells was robust compared to the others,
which is consistent with our previous data [16]. Both KL cells and
SL cells showed a less level of small/large colony forming activity,
while CD34
+ cells demonstrated a further low activity. In the cell
culture assay and in vivo assays, CD34
+ cells had the highest
activity. It seems to be controversial that CD34
+ cells are the most
functional cells, but they can only form a few colonies. In fact, it is
not surprising and very reasonable. Because CD34
+ cells count
12.2360.02% in BMMNCs, while KL cells count 3.73760.004%,
SL cells count 1.32760.001%, KSL count 0.59760.001%,
respectively, which indicates CD34
+ cells are partially differenti-
ated cells. In EPC differentiation hierarchy, it was confirmed that
small EPC colonies are capable of differentiation into large EPC
colonies and that large colonies can further differentiate into
adherent, more vasculogenic EPCs in culture (unpublished data by
Masuda et al) (Figure 11). In addition, small EPC colonies have a
predominant stem cell-like potential for proliferation and large
EPC colonies possess a predominantly vasculogenic potential
including cell adhesion, tube formation activity in vitro and
contribution to de novo blood vessel formation in ischemic tissue
(Kwon et al [16], unpublished data by Masuda et al and Tsukada
et al and Figure S2) (Figure 11). Taken the EPC differentiation and
in vivo data together, our results suggest that KSL cells are most
Figure 9. Histological analysis for arterioles in ischemic myocardium. KSL, KL, SL, CD34
+ cells and PBS control were systemically injected 3
days after MI induction. Heart samples were harvested following BS1 lectin systemic perfusion 28 days after cell injection. a, Arterioles were visualized
following a-smooth muscle actin staining. b, The numbers of arterioles were counted in bilateral sides of the peri-infarct zone on LV cross sections
and averaged in each group (n=3), respectively.
doi:10.1371/journal.pone.0020219.g009
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+ cells are most differentiating population
in mouse EPCs that we studied (Figure 11). Therefore we
hypothesize the possible differentiation hierarchy of KSL, KL,
SL and CD34
+ cells (Figure 11).
Consequently, our data demonstrates that CD34 may be a
better and more suitable marker for mouse functional EPCs with
higher homing and vasculogenic properties, which could benefit
the investigation of therapeutic EPC biology. Assuming the
heterogeneity of CD34
+ population, more vasculogenic fraction
co-expressing another marker may exist in the mouse bone
marrow CD34
+ cells. The search for a truly selective EPC marker,
marking ‘‘real’’ EPCs in combination with CD34, has thus to be
continued.
Materials and Methods
Animals
C57BL6/J mice (male, 8–12 weeks old) were used for all
experiments. Transgenic mice that constitutively expressb-galac-
tosidase (b-gal) under the control of the LacZ gene (B6;129S-
Gt[ROSA]26Sor/J, male, 8–12 weeks old) were purchased from
Jackson Laboratories (ME, USA) and used for in vivo experiments
in which genetically labeled (positive for the LacZ gene) 50,000
SL, KL, KSL and CD34
+ cells were systemically injected into wild
type recipient mice after MI surgery.
Preparation of KSL, KL, SL and CD34
+ Cells
Bone marrow cells were harvested from hipbones, femurs,
tibiae, shoulder bones, ulnas, vertebra and sternum of mice.
BMMNCs were isolated from total bone marrow cells by
subsequent purification over Histopaque gradients. BMMNCs of
WT and ROSA26 mice were incubated with FITC-conjugated
anti-CD34 antibody (BD Pharmingen) for 30 minutes at 4uC and
CD34
+ cells were further isolated using FACS Aria (BD
Biosciences). For SL, KL and KSL cell isolation, BMMNCs were
incubated with a cocktail of biotinylated monoclonal antibodies
against lineage markers (BD IMag) for 15 minutes at 4uC. These
cells were further incubated with streptavidin-conjugated magnetic
nanoparticles (BD IMag) for 30 minutes. After depletion of lineage
positive cells, lineage negative cells were subsequently incubated
with PE-conjugated anti-Sca-1 antibody, (BD Pharmingen), APC-
conjugated anti-c-Kit antibody (BD Pharmingen) and APC Cy7-
conjugated streptavidin (BD Pharmingen) for 30 minutes at 4uC
followed by isolation of the desired different sub-fractions KSL,
KL and SL by FACS Aria (BD Biosciences).
EPC Colony Forming Assay
The number of EPC colonies was assessed by EPC colony
forming assay that we have developed recently [16,22]. The KSL,
KL, SL and CD34
+ cells (500 cells/well) were cultured in methyl
Figure 10. Functional analysis of treated hearts by echocardiography. Echocardiographic parameters for cardiac function 28 days vs. 7 days
after myocardial infarction and treatments. The following parameters: left ventricular end diastolic diameter (LVEDD) (a), left ventricular end systolic
diameter (LVESD) (b), left ventricular ejection fraction (EF) (c) and left ventricular fractional shortening (FS) (d) were measured in the PBS-, the KSL-, the
KL-, the SL- and the CD34
+ cell-injected groups, and change of each parameter between day 7 and day 28 after surgery was calculated and averaged
(n=3).
doi:10.1371/journal.pone.0020219.g010
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Vancouver, Canada) with the following supplements in 6-well
culture plates (Primaria, BD Falcon) for 7 days: 50 ng/ml of
vascular endothelial growth factor (VEGF) (R&D Systems, MN),
20 ng/ml of stem cell factor (SCF) (KIRIN, Japan), 50 ng/ml of
epidermal growth factor (EGF) (Wako, Japan), 20 ng/ml of
interleukin-3 (KIRIN, Japan), 50 ng/ml of insulin-like growth
factor-1 (IGF-1) (Wako, Japan), 50 ng/ml of basic fibroblast
growth factor (bFGF) (Wako, Japan), 2 U/mL of heparin
(AJINOMOTO, Japan) and 10% FBS. EPC-Colony Forming
Units (CFUs) were identified as large-EPC-CFUs or small-EPC-
CFUs by visual inspection with an inverted microscope under 406
magnification. Large-EPC-CFUs are mainly composed of spindle-
shaped cells whereas small-EPC-CFUs are aggregates of small
round cells. The endothelial phenotype of the EPC colonies was
confirmed by their high up-take of acetylated low density
lipoprotein (acLDL, Biomedical Technologies Inc, Stoughton,
MA) and immunocytochemical positivity for isolectin B4 (Molec-
ular Probes, CA). The total numbers of colonies with small-EPC-
CFUs and large-EPC-CFUs were counted in the entire view fields
of each culture plate and averaged.
Collection and phenotypes of small and large colonies
After removal of methylcellulose containing floating and
hematopoietic cells by cold PBS (1 ml/well) in 6-well plates, white
spotty colonies (small colonies) were flushed gently with 1 ml of
cold PBS for 3 times and collected. One ml of cold EDTA/PBS
(5mmol/L) was then added to each well. The plates were then
incubated for 5 minutes at 37uC and large colonies were collected.
Small colonies and large colonies were incubated with PE-
conjugated anti-CD19 antibody, PE-conjugated anti-CD3 anti-
body, PE-conjugated anti-CD14 antibody, PE-conjugated anti-
CD41 antibody, PE-conjugated anti-CD31 antibody, PE-conju-
gated anti-Flk-1 antibody, PE-conjugated anti-Tie-2 antibody, PE-
conjugated anti-Sca-1 antibody, APC-conjugated anti-VE-cad-
herin antibody, APC-conjugated anti-CD45 antibody, APC-
conjugated anti-c-Kit antibody (BD Pharmingen), respectively,
for 30 minutes at 4uC.After washing with PBS for 2 times, cells
were analyzed by FACS Aria (BD Biosciences).
EPC Culture Assay
Cellular adhesion capacity was evaluated as described previ-
ously [46]. Briefly, freshly isolated cells (10
5 cells/well) were seeded
in 20% fetal bovine serum (FBS)/EGM-2MV medium (Lonza) on
a 8-well chamber slide coated with ProNectin F (Sigma), and
cultured for 7 days at 37uC under 5%CO2. Each well was then
washed 3 times with PBS and the attached cells were fixed with
4% paraformaldehyde (PFA)/phosphate buffer saline (PBS) and
stained with DAPI. The attached cells were visualized under a
fluorescence microscope and counted. The adhesive activity of
each cell group was evaluated as the mean number of attached
cells in each group.
Immunocytochemistry
Cell samples were prepared for EPC culture assay as described
above. Each cell-containing well was then washed three times with
PBS and attached cells were briefly fixed with 4% PFA/PBS. For
improved detection of intracellular proteins, cells were permeabi-
lized by incubation in 0.1% Triton X-100/PBS solution for 5 min
at room temperature (RT) followed by a three time rinse with PBS.
Samples were blocked in antibody dilution buffer 2% BSA/PBS
for 1 hour at RT. After removal of the blocking solution, primary
antibodies were added: anti-VE-cadherin antibody (Santa Cruz,
1:100), anti-vWF antibody (Chemicon, 1:100), anti-Flk-1 antibody
(Chemicon, 1:100), anti-CD45 antibody (Abcam, 1:200), anti-
CD34 antibody (Abcam, 1:50), anti-CD146 antibody (Abcam,
Figure 11. Stem/progenitor differentiation hierarchy of KSL, KL, SL and CD34
+ cells. In EPC-CFA, small EPC colonies are capable of
differentiating into large colonies and large EPC colonies can further differentiate into adherent, more vasculogenic non-colony forming EPCs in
culture. Small colonies reveal a predominant potential for proliferation, while large colonies demonstrate a predominantly vasculogenic potential
including cell adhesion and tube-like structure formation in vitro (unpublished data, lower panel). Based on the EPC colony numbers of KSL, KL, SL
and CD34
+ cells, the conceivable extent of homing capacity (Y-axis) and differentiation status (X-axis) in each cell type is indicated in the upper panel.
doi:10.1371/journal.pone.0020219.g011
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three times with PBS for 5 min each, cells were incubated with
secondary antibodies prepared at 1:500 in antibody dilution
buffer: Alexa 488 donkey anti-goat IgG, Alexa 488 goat anti-
rabbit IgG and Alexa 488 goat anti-rat IgG (MP/Invitrogen) for
30 min at RT. After secondary antibodies were removed and cells
were washed with PBS for three times, DAPI solution (Sigma,
1:5000) was added and nuclei were stained for 10 min at RT.
Mounting medium and a cover-slip were added to the glass slide
followed by sealing samples with nail varnish before evaluation of
the staining results under fluorescence microscopy.
Quantitative Real-time RT-PCR
Total RNA was isolated from cell samples using RNeasy Mini
kit (QIAGEN) according to the manufacturer’s instructions. cDNA
was synthesized using PrimeScript RT reagent Kit (TAKARA
BIO Inc., Japan). For quantitative RT-PCR, the converted cDNA
samples (2 ml) were amplified in triplicate in a final volume of 10 ml
using SYBR Green Master Mix reagent (Applied Biosystems) and
gene-specific primers with an ABI Prism 7700 RT-PCR machine
(Applied Biosystems). Melting curve analysis was performed with
Dissociation Curves software (Applied Biosystems) and the mean
cycle threshold (Ct) values were used to calculate gene expression
levels with normalization to mouse GAPDH.
RT-PCR Primers
mGAPDH: forward: ACATCATCCCTGCATCCACT; re-
verse: CACATTGGGGGTAGGAACAC, mvWF: forward: ACG-
CCATCTCCAGATTCAAG, reverse: AAGCATCTCCCACAG-
CATTC, mVE-Cadherin: forward: TACTCAGCCCTGCTCT-
GGTT, reverse: GCTTGCAGAGGCTGTGTCTT, mFlk-1: for-
ward: GGGTTTGGTTTTGGAAGGTT, reverse: CACGTAA-
GAGTCCGGAAGGA, mIntegrin beta 2: forward: GTACA-
GGCGCTTTGAGAAGG, reverse: TTTCAGCAAACTTGG-
GGTTC, mCXCR4: forward: TGCTGTGTGATGGTTTGT-
TTG, reverse: AAACCCCCAGCATTTCTACC.
In Vitro Incorporation Assay
HUVECs and freshly isolated cells were used for tube formation
assays as described previously [46]. CD34
+, SL, KL, and KSL cells
were labeled with DiI for 20 minutes. After washing with PBS,
2,000 of the DiI-labeled cells were mixed with 40,000 HUVECs in
100 mL of 10% FBS/EGM-2MV medium (Lonza) in order to
evaluate the contribution of EPCs to EC-derived tube formation.
One hundred ml of cell suspensions were applied to 100 mlo f
Matrigel (BD Biosciences) coated wells in an 8-well glass chamber
slide (BD Falcon), and then incubated for 48 hours. The number
of formed tubes and incorporated DiI-labeled cells were counted
and averaged with the help of a computer assisted fluorescent
microscope (OLYMPUS, Japan).
Surgical Procedure
Institutional Animal Care and Use Committee in Institute of
Biomedical Research and Innovation and RIKEN Center for
Developmental Biology approved all the following research
protocols (approval ID: AH21-01), including surgical procedures
and animal care. Mice were anesthetized with 0.015 mg/kg of
Avertin
TM (Sigma). Myocardial infarction (MI) was induced as
described previously [47]. Briefly, after the fourth to fifth intercostal
space was opened, the heart was exteriorized and the pericardium
was incised. Thereafter, the heart was held with a fine forceps, and
MI was induced by ligation of the left anterior descending coronary
artery at the just proximal site of the bifurcation of a diagonal
branch with a 7-0 nylon suture followed by thorax closure. For in
vivo study,50,000 KSL, KL, SL and CD34
+cells togetherwith PBS
control were systemically injected 3 days after MI.
Physiological Assessment of LV Function Using
Echocardiography
Transthoracic echocardiography (SONOS 5500, Philips Med-
ical Systems) was performed to evaluate LV function immediately
before and 7 and 28 days after MI. After anesthesia with
Avertin
TM (Sigma), left ventricular end diastolic diameter
(LVEDD), left ventricular end systolic diameter (LVESD), left
ventricular ejection fraction (EF) and left ventricular fractional
shortening (FS) were measured at the midpapillary muscle level.
All procedures and analysis were performed by an experienced
researcher who was blinded to treatment.
Tissue Harvesting
For cell recruitment studies, MI-induced mouse hearts were
harvested 24 hours after cell injection and prepared for frozen
tissue sectioning after fixation with 4% PFA/PBS. For cell
retention studies, MI-induced mice were anesthetized 28 days
after surgery. Griffonia (Bandeiraea) Simplicifolia lectin 1 (Vector,
0.1 mg per mouse) was then injected systemically by direct cardiac
puncture. Ten minutes later, the animals were euthanized, and
hearts were harvested and prepared for paraffin tissue sectioning
after fixation with 4% PFA/PBS.
Morphometric Evaluation of Infarct Size
To elucidate the severity of myocardial fibrosis, Masson
trichrome staining was performed on frozen sections from each
tissue block, and the stained sections were used to measure the
average ratio of fibrosis area to entire LV cross-sectional area
(percent fibrosis area) and the average ratio of fibrosis length to
entire internal LV circumference (percent fibrosis length).
Immunofluorescence Staining
The sections were stained with rabbit anti-b-gal antibody
(Cortex, 1:1000) and antibody to Griffonia (Bandeiraea) Simplici-
folia lectin1 (Vector,1:100),thenwashedwith PBSandstainedwith
AlexaFluor488ratanti-rabbit IgGand AlexaFluor546rabbitanti-
goat IgG (MP/Invitrogen, 1:1000) at RT for one hour. Nuclei were
counterstained with DAPI (Sigma, 1:5000), and sections were
mounted in aqueous mounting medium. Images were examined
using a confoal microscope (OLYMPUS, Japan). To detect
arterioles, the sections were stained with anti-a smooth muscle
actin (SMA) antibody (Dako, 1:250), then washed with PBS and
stained with Alexa Fluor 594 donkey anti-mouse IgG2a (MP/
Invitrogen, 1:1000) at RT for one hour. Nuclei were counterstained
with DAPI, and sections were mounted in aqueous mounting
medium. Images were examined using a fluorescence microscope.
Statistical analysis
All values were presented as mean 6 SEM. Statistical analyses
were performed with commercially available software (GraphPad
Prism
TM, MDF Co Ltd, Japan). Comparisons between multiple
groups were tested for significance via analysis of variance
(ANOVA) followed by post-hoc testing with the Tukey’s procedure.
A P value less than 0.05 was considered statistically significant.
Supporting Information
Figure S1 CD34 positivity in KSL, KL and SL cells. KSL
cells were isolated from BMMNCs and further examined for
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PLoS ONE | www.plosone.org 12 May 2011 | Volume 6 | Issue 5 | e20219CD34 expression by FACS. The analyzed data was shown as
histogram. The percent of CD34 positivity was indicated in each
histogram.
(TIF)
Figure S2 Phenotypes of large and small colonies. Large
colonies and small colonies were collected separately after 7 days
culture in methylcellulose medium. Phenotypes of large colonies
(a) and small colonies (b) were analyzed by FACS. The analyzed
data was shown as histogram. The percent of each positive
population was indicated in each histogram.
(TIF)
Figure S3 Assessment of CD45, CD146 and CD34 in
cultured KSL, KL, SL, and CD34
+ cells by immunocy-
tostaining. Freshly isolated cells were cultured in 20%FBS/
EGM-2MV medium on vitronectin-coated 4 well-chamber slides
for 7 days. Adherent cells were stained with CD45, CD146 and
CD34. The assay was triplicated and demonstrated similar results.
(TIF)
Figure S4 Endothelial marker expressions in freshly
isolated mouse CD34+ cells. CD34
+ cells were isolated from
mouse BMMNCs (10
5 cells/mL) and further examined for CD31
(a), VE-cadherin (b), Flk-1 (c) and Tie-2 (d) expressions by FACS.
The percent of each positive cell population was indicated in the
contour plots.
(TIF)
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